Y Ye, Y Zhang, N Yang, Q Gao,
X Ding, X Kuang… - The Innovation, 2022 - cell.com
Immune checkpoint blockade (ICB) therapies exhibit substantial clinical benefit in different
cancers, but relatively low response rates in the majority of patients highlight the need to …